Literature DB >> 8970352

Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance.

D Olson1, A Pohlman, J B Hall.   

Abstract

Tissue hypoxia resulting from regional blood flow abnormalities and oxygen extraction defects may underlie the pathogenesis of multiple system organ failure (MSOF) in sepsis. Low-dose dopamine (LDD) is widely employed to enhance splanchnic perfusion although data to support this approach are lacking. We assessed the effect of LDD on surrogate markers of renal and gastric perfusion. Sixteen nonoliguric mechanically ventilated patients with sepsis syndrome received LDD (3 micrograms/kg/min) or placebo in a double-blind crossover design experiment. Hemodynamics, gastric intramucosal pH (pHi) urine volumes, urinary sodium excretion, and cimetidine-corrected creatinine clearance were compared. Mortality for the group was 63%. LDD caused a significant increase in urine volume (88 +/- 58 to 115 +/- 70 ml/h, p = 0.02, 95% confidence interval for change 4.7 to 49 ml/h), but no significant change in any other parameter. We conclude that use of LDD results in diuresis but does not improve other markers of renal or gut perfusion. These data do not support the use of LDD to reduce risk of progression to MSOF in sepsis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970352     DOI: 10.1164/ajrccm.154.6.8970352

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  3 in total

Review 1.  [Microcirculatory monitoring of sepsis].

Authors:  A Bauer; D Bruegger; F Christ
Journal:  Anaesthesist       Date:  2005-12       Impact factor: 1.041

Review 2.  The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients.

Authors:  E Christiaan Boerma; Can Ince
Journal:  Intensive Care Med       Date:  2010-09-02       Impact factor: 17.440

Review 3.  Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock.

Authors:  Pierre Asfar; Daniel De Backer; Andreas Meier-Hellmann; Peter Radermacher; Samir G Sakka
Journal:  Crit Care       Date:  2003-12-29       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.